International Journal of Management and Applied Science (IJMAS)
.
Follow Us On :
current issues
Volume-10,Issue-1  ( Jan, 2024 )
Past issues
  1. Volume-10,Issue-1  ( Jan, 2024 )
  2. Volume-9,Issue-12  ( Dec, 2023 )
  3. Volume-9,Issue-11  ( Nov, 2023 )
  4. Volume-9,Issue-10  ( Oct, 2023 )
  5. Volume-9,Issue-9  ( Sep, 2023 )
  6. Volume-9,Issue-8  ( Aug, 2023 )
  7. Volume-9,Issue-7  ( Jul, 2023 )
  8. Volume-9,Issue-6  ( Jun, 2023 )
  9. Volume-9,Issue-5  ( May, 2023 )
  10. Volume-9,Issue-4  ( Apr, 2023 )

Statistics report
Apr. 2024
Submitted Papers : 80
Accepted Papers : 10
Rejected Papers : 70
Acc. Perc : 12%
Issue Published : 119
Paper Published : 5065
No. of Authors : 10504
  Journal Paper


Paper Title :
A Study of Investment Analysis of Selected Pharmaceutical Companies of India

Author :Saadul Haque, G.Sunitha, Durga Prasad Navulla, Jhansi Rani Bodra

Article Citation :Saadul Haque ,G.Sunitha ,Durga Prasad Navulla ,Jhansi Rani Bodra , (2018 ) " A Study of Investment Analysis of Selected Pharmaceutical Companies of India " , International Journal of Management and Applied Science (IJMAS) , pp. 68-81, Volume-4,Issue-9

Abstract : Indian Pharmaceutical Industry is profoundly divided, with more than 20,000 enlisted organizations, with top 25 organizations controlling 70% approx. of the Indian market. The significant centre points of Indian Pharmaceutical organizations are settled in Maharashtra, Gujarat, Andhra Pradesh, Himachal Pradesh (Baddi). 45% of the aggregate number of assembling organizations is in Maharashtra and Gujarat. 70% of India's request is met by Indian Pharmaceutical Industry as Bulk Drugs, Intermediates, Formulations, chemicals, tablets, cases, orals, infusions, powders, immunizations and so forth. Indian Pharma industry was basically worked and controlled by overwhelming remote organizations – Multi National Companies (MNCs), having backups in India because of accessibility of shoddy work and minimal effort. MNCs were controlling very nearly 70% of Indian Market. The 1970 Indian Patent Act, propelled industry for vast size of generation of mass medications. This prompted the change in the Industry. The imports of the medications got diminished, since; indigenous medications began supplanting the same. This further prompted an expansion in utilization and extraordinary development in definitions exercises. This development was led by the Indian organizations. Gradually however without a doubt, MNCs began losing their mastery and a piece of the overall industry. Like some other industry, home-grown Pharma industry is a blend of open and private endeavour. Keywords - Pharmaceutical Industry, Investment Analysis, Ratio Analysis

Type : Research paper

Published : Volume-4,Issue-9


DOIONLINE NO - IJMAS-IRAJ-DOIONLINE-13569   View Here

Copyright: © Institute of Research and Journals

| PDF |
Viewed - 56
| Published on 2018-11-22
   
   
IRAJ Other Journals
IJMAS updates
IJMAS -THANK YOU ALL FOR CONTRIBUTING YOUR PAPER TO IJMAS MAY ISSUE. ALL AUTHORS ARE REQUESTED TO GET THEIR HARD COPY NOW.
The Conference World
Facebook

JOURNAL SUPPORTED BY